
Virax Biolabs Group Limited
VRAXHealthcare|Biotechnology|GB
$0.79
-0.39 (-32.89%)
DCF Value
$14.60
Tangible Book / Share
$18.45
Cash / Share
$16.39
Next Earnings Report
Dec 2, 2026
EPS est. -$1.75 · Revenue est. $13.9K
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Sep 10, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Oct 29, 2026 · PRNewsWire
SEC Filings (48)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 10, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 4, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 4, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 3, 2026 | EFFECT | DocumentIndex | |
| Sep 2, 2026 | F-3/A | Shelf registration | DocumentIndex |
| Aug 26, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 18, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 31, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 24, 2026 | F-3 | Shelf registration | DocumentIndex |
| Jul 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 10, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 6, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Jun 24, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 12, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 26, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 14, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 10, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 18, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 31, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 30, 2025 | EFFECT | DocumentIndex | |
| Dec 18, 2025 | F-3 | Shelf registration | DocumentIndex |
| Dec 18, 2025 | D | DocumentIndex | |
| Dec 4, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 2, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 29, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 30, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 2, 2025 | 20-F | Annual report (foreign) | DocumentIndex |
| Jun 13, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 18, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 13, 2025 | 6-K | Foreign issuer report | DocumentIndex |